查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
患者匹配 AI 临床试验解决方案市场规模、份额和趋势分析报告：按治疗用途、最终用途、地区、细分市场预测，2022-2030 年
市场调查报告书
商品编码
1147574

患者匹配 AI 临床试验解决方案市场规模、份额和趋势分析报告：按治疗用途、最终用途、地区、细分市场预测，2022-2030 年

AI-based Clinical Trial Solutions For Patient Matching Market Size, Share & Trends Analysis Report By Therapeutic Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

患者匹配 AI 临床试验解决方案的市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，全球患者匹配 AI 临床试验解决方案的市场规模在预测期内将实现 26.7% 的复合年增长率 (CAGR)，到 2030 年将达到 19% . 预计将达到数十亿美元。行业增长的主要驱动力是全球慢性病发病率增加、扩大医疗保健部门的投资增加以及新技术的引入。

此外，越来越多地采用基于人工智能 (AI) 的技术进行临床试验，以及该领域初创企业的兴起也为市场带来了新的机遇。例如，2022 年 2 月，Qureight 为其基于 AI 的平台筹集了 150 万美元的种子资金，这将有助于缩短临床试验过程的时间，并进一步降低药物开发成本。领先的生物製药巨头正在实施先进的技术解决方案，以改善患者管理和临床试验结果。

这些平台进一步缩短了临床试验週期时间和成本，并提高了临床试验开发的生产力和准确性。基于 AI 的解决方案结合了自然语言处理 (NLP) 算法，以提高临床试验和患者註册之间的匹配率。例如，患者匹配 AI 临床试验解决方案使肺癌试验研究中的患者招募增加了 58.4%。这些优势进一步推动了市场的增长。

基于治疗用途，由于全球癌症患病率上升以及开发癌症治疗解决方案的举措不断增加，肿瘤学将在 2021 年成为最大的市场。它的市场份额为 23.2%。然而，由于心脏病发作和中风等病例的增加，预计心血管疾病领域在预测期内将呈现最快的增长速度。

按最终用户划分，製药公司的收入份额最高，为 66.0%。这将使製药行业的主要参与者专注于使用基于 AI 的技术更好地开发生物标誌物和诊断方法来识别新的药物靶点，从而简化药物开发和临床试验过程。这是因为

按地区划分，2021 年北美将占据 43.8% 的最大市场份额。然而，由于基于 AI 的临床技术的渗透率不断提高以及政府对采用 AI 的努力的支持，预计亚太地区在预测期内将呈现最快的增长。

基于人工智能的患者匹配临床试验解决方案市场报告要点

2021 年患者匹配 AI 临床试验解决方案的全球市场规模为 2.306 亿美元，受慢性病患病率上升和临床试验过程中基于 AI 技术的日益采用的推动

>

到 2021 年，根据治疗用途，肿瘤学将占最高收入份额，达到 23.2%。全球癌症患病率上升导致临床试验数量增加，这对市场产生了积极影响

2021 年，製药公司在最终用途方面的收入份额最高，为 66.0%。这种增长归因于在临床试验中越来越多地使用基于 AI 的解决方案

由于主要参与者的存在、与生活方式相关的疾病的增加、老年人口的增加以及医疗保健领域进展的扩大，2021 年北美将占患者匹配 AI 临床试验解决方案总量的 43.8%医疗保健领域。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 市场定义
  • 调查方法
    • 信息采购
      • 购买的数据库
      • GVR 内部数据库
    • 初步调查
  • 调查范围和假设
  • 数据源列表

第 2 章执行摘要

  • 市场展望
  • 细分市场展望

第 3 章全球患者匹配 AI 临床试验解决方案市场变量、趋势和范围

  • 描绘渗透率和增长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 患者匹配 AI 临床试验解决方案市场分析工具
    • 行业分析 - 搬运工
      • 供应商的议价能力
      • 买家的议价能力
      • 替代威胁
      • 来自新进入者的威胁
      • 竞争公司之间的敌对关係
  • PESTEL 分析
    • 政治形势
    • 经济和社会状况
    • 技术概况
    • 法律状况
    • 技术概况
  • 对主要交易和战略联盟的分析
  • COVID-19 对市场的影响

第 4 章患者匹配 AI 临床试验解决方案市场：治疗应用估计和趋势分析

  • 定义和范围
  • 全球患者匹配 AI 临床试验解决方案：治疗应用市场份额分析，2021 年和 2030 年
  • 肿瘤学
  • 心血管疾病
  • 神经系统疾病或病症
  • 代谢性疾病
  • 感染
  • 其他

第 5 章患者匹配 AI 临床试验解决方案市场：最终用途估计和趋势分析

  • 定义和范围
  • 全球患者匹配 AI 临床试验解决方案：最终用途市场份额分析，2020 年和 2030 年
  • 製药公司
  • 学术界
  • 其他

第 6 章患者匹配 AI 临床试验解决方案市场：按治疗用途和最终用途划分的区域估计和趋势分析

  • 全球患者匹配 AI 临床试验解决方案：区域差异分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 意大利
    • 俄罗斯
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第七章公司简介

  • Unlearn.AI, Inc.
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Antidote Technologies, Inc.
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Deep6.ai
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 孟德尔.ai
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 阿里斯全球
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 深度镜头 AI
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • AmeriSourceBergen 公司
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 科内克萨
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 微软公司
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • GNS 医疗保健
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
Product Code: GVR-4-68039-982-8

AI-based Clinical Trial Solutions For Patient Matching Market Growth & Trends:

The global AI-based clinical trial solutions for patient matching market size is expected to reach USD 1.9 billion by 2030, registering a compound annual growth rate (CAGR) of 26.7% during the forecast period, according to a new report by Grand View Research, Inc. The major factors attributing the industry growth are the increasing worldwide incidences of chronic diseases, rising investment in the expansion of the healthcare sector, and the introduction of new technologies.

The rising adoption of artificial intelligence(AI)-based technologies for conducting clinical trials and the increasing number of start-ups in this field are also opening new opportunities for the market. For instance, in February 2022, in their seed funding, Qureight raised USD 1.50 million for their AI-based platform which reduces the timeline for the clinical trials process and further helps in reducing the cost of medicine development. Major bio-pharma giants are implementing advanced technological solutions for better patient management and clinical trial results.

These platforms further reduce clinical trial cycle time & cost, thereby increasing productivity & accuracy of the trial development. AI-based solutions incorporate natural language processing (NLP) algorithms which enhances the match rate between clinical trials and patient enrollment. For instance, AI-enabled clinical trial solutions used in matching patients have increased patient recruitment in lung cancer trial studies by 58.4%. Such advantages are further driving the market growth.

Based on therapeutic application, oncology held the largest market share 23.2% in 2021 owing to the rise in the prevalence of cancer all over the globe and rising initiatives to develop therapeutic solutions for oncology. However, the cardiovascular disease segment is expected to show the fastest growth rate during the forecast period owing to increasing cases of heart attack, stroke, and others.

Based on end users, pharmaceutical companies accounted for the highest revenue share of 66.0% owing to the growing focus on better development of bio-markers and diagnostics using AI-based technologies to identify the new medicine target and simplify the process of development of medicine and clinical trials by key players of pharmaceutical companies.

Based on the region North America held the largest market share of 43.8% in 2021. However, Asia Pacific is expected to show the fastest growth rate during the forecast period due to the increasing penetration of AI-based clinical technologies and supportive government initiatives for adopting AI.

AI-based Clinical Trial Solutions For Patient Matching Market Report Highlights:

  • The global AI-based clinical trial solutions for patient matching market size was valued at USD 230.6 million in 2021, owing to the increasing prevalence of chronic diseases and growing adoption of AI-based technologies in the clinical trial process
  • In 2021, based on therapeutic applications, oncology accounted for the highest revenue share of 23.2%. The growing penetration rate of cancer throughout the world is leading to an increase in the number of clinical trials and thus, impacting the market positively
  • In 2021, pharmaceutical companies accounted for the highest revenue share of 66.0% based on end-use. The growth is attributed to the rising usage of AI-based solutions for clinical trials
  • North America dominated the AI-based clinical trial solution for patient matching with 43.8% of the total share in 2021, owing to the presence of key players, increasing prevalence of lifestyle disorders, growing elderly population, and growing advancement in the healthcare sector

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definition
  • 1.3 Research Methodology
    • 1.3.1 Information Procurement
      • 1.3.1.1 Purchased database
      • 1.3.1.2 GVR's internal database
    • 1.3.2 Primary Research
  • 1.4 Research Scope and Assumptions
  • 1.5 List of Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Global AI-based Clinical Trial Solutions for Patient Matching Market Variables, Trends, & Scope

  • 3.1 Penetration and Growth Prospect Mapping
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Global AI-based Clinical Trial Solutions for Patient Matching Market Analysis Tools
    • 3.3.1 Industry Analysis - Porter's
      • 3.3.1.1 Bargaining power of the suppliers
      • 3.3.1.2 Bargaining power of the buyers
      • 3.3.1.3 Threats of substitution
      • 3.3.1.4 Threats from new entrants
      • 3.3.1.5 Competitive rivalry
  • 3.4. PESTEL Analysis
    • 3.4.1 Political landscape
    • 3.4.2 Economic and Social landscape
    • 3.4.3 Technology landscape
    • 3.4.4 Legal landscape
    • 3.4.5 Technology landscape
  • 3.5. Major Deals & Strategic Alliances Analysis
  • 3.6 COVID-19 Impact on the market

Chapter 4 AI-based Clinical Trial Solutions for Patient Matching Market: Therapeutic Application Estimates & Trend Analysis

  • 4.1 Definitions & Scope
  • 4.2 Global AI-based Clinical Trial Solutions for Patient Matching Market: Therapeutic Application Market Share Analysis, 2021 and 2030
  • 4.3 Oncology
    • 4.3.1 Oncology analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.4 Cardiovascular Diseases
    • 4.4.1 Cardiovascular Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.5 Neurological Diseases or Conditions
    • 4.5.1 Neurological Diseases or Conditions Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.6 Metabolic Diseases
    • 4.6.1 Metabolic Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.7 Infectious Diseases
    • 4.7.1 Infectious Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.8 Others
    • 4.8.1 Others analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)

Chapter 5 AI-based Clinical Trial Solutions for Patient Matching Market: End-Use Estimates & Trend Analysis

  • 5.1 Definitions & Scope
  • 5.2 Global AI-based Clinical Trial Solutions for Patient Matching Market: End-Use Market Share Analysis, 2020 and 2030
  • 5.3 Pharmaceutical Companies
    • 5.3.1 Pharmaceutical Companies Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 5.4 Academia
    • 5.4.1 Academia analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Others analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)

Chapter 6 AI-based Clinical Trial Solutions for Patient Matching Market: Regional Estimates & Trend Analysis, By Therapeutic Application & End-Use

  • 6.1 Global AI-based Clinical Trial Solutions for Patient Matching Market: Regional Movement Analysis
  • 6.2 North America
    • 6.2.1 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts ByTherapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.2 U.K.
      • 6.3.2.1 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts by Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.4 Spain
      • 6.3.4.1 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.5 France
      • 6.3.5.1 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.6 Italy
      • 6.3.6.1 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.7 Russia
      • 6.3.7.1 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.3 Japan
      • 6.4.3.1 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.4 India
      • 6.4.4.1 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.5 South Korea
      • 6.4.5.1 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.6 Australia
      • 6.4.6.1 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.5.4 Argentina
      • 6.5.4.1 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Unlearn.AI, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Performance
    • 7.1.3 Product Benchmarking
    • 7.1.4 Strategic Initiatives
  • 7.2 Antidote Technologies, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Performance
    • 7.2.3 Product Benchmarking
    • 7.2.4 Strategic Initiatives
  • 7.3 Deep6.ai
    • 7.3.1 Company Overview
    • 7.3.2 Financial Performance
    • 7.3.3 Product Benchmarking
    • 7.3.4 Strategic Initiatives
  • 7.4 Mendel.ai
    • 7.4.1 Company Overview
    • 7.4.2 Financial Performance
    • 7.4.3 Product Benchmarking
    • 7.4.4 Strategic Initiatives
  • 7.5 Aris Global
    • 7.5.1 Company Overview
    • 7.5.2 Financial Performance
    • 7.5.3 Product Benchmarking
    • 7.5.4 Strategic Initiatives
  • 7.6 Deep Lens AI
    • 7.6.1 Company Overview
    • 7.6.2 Financial Performance
    • 7.6.3 Product Benchmarking
    • 7.6.4 Strategic Initiatives
  • 7.7 AmeriSourceBergen Corporation
    • 7.7.1 Company Overview
    • 7.7.2 Financial Performance
    • 7.7.3 Product Benchmarking
    • 7.7.4 Strategic Initiatives
  • 7.8 Koneksa
    • 7.8.1 Company Overview
    • 7.8.2 Financial Performance
    • 7.8.3 Product Benchmarking
    • 7.8.4 Strategic Initiatives
  • 7.9 Microsoft Corporation
    • 7.9.1 Company Overview
    • 7.9.2 Financial Performance
    • 7.9.3 Product Benchmarking
    • 7.9.4 Strategic Initiatives
  • 7.10 GNS Healthcare
    • 7.10.1 Company Overview
    • 7.10.2 Financial Performance
    • 7.10.3 Product Benchmarking
    • 7.10.4 Strategic Initiatives

List of Tables

  • TABLE 1 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 2 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 3 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 4 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 5 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 6 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 7 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 8 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 9 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 10 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 11 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 12 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 13 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 14 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 15 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 16 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 17 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 18 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 19 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 20 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 21 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 22 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 23 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 24 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 25 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 26 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 27 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 28 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 29 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 30 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 31 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 32 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 33 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 34 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 35 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 36 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 37 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 38 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 39 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 40 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 41 Middle East & Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 42 Middle East & Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 43 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 44 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 45 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 46 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 47 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 48 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 AI-based Clinical Trial Solutions for Patient Matching market snapshot, 2021 (USD Million)
  • FIG. 6 AI-based Clinical Trial Solutions for Patient Matching market trends & outlook
  • FIG. 7 Penetration & growth prospect mapping
  • FIG. 8 Market driver analysis (Current & future impact)
  • FIG. 9 Market restraint analysis (Current & future impact)
  • FIG. 10 AI-based Clinical Trial Solutions for Patient Matching market, therapeutic application outlook key takeaways (USD Million)
  • FIG. 11 AI-based Clinical Trial Solutions for Patient Matching market: therapeutic application movement analysis (USD Million), 2020 & 2030
  • FIG. 12 Oncology Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 13 Cardiovascular diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 14 Neurological Diseases or Conditions Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 15 Metabolic Diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 16 Infectious Diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 17 Other Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 18 AI-based Clinical Trial Solutions for Patient Matching market, end-use outlook key takeaways (USD Million)
  • FIG. 19 AI-based Clinical Trial Solutions for Patient Matching market: end-use movement analysis (USD Million), 2020 & 2030
  • FIG. 20 Pharmaceutical companies Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 21 Academia Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 22 Others Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 23 AI-based Clinical Trial Solutions for Patient Matching market, regional outlook key takeaways (USD Million)
  • FIG. 24 AI-based Clinical Trial Solutions for Patient Matching market: Regional movement analysis (USD Million), 2020 & 2030
  • FIG. 25 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 26 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 27 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 28 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 29 U.K AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 30 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 31 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 32 France-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 33 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 34 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 35 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 36 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 37 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 38 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 39 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 40 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 41 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 42 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 43 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 44 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 45 MEA AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 46 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 47 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 48 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)